Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.390
+0.010 (0.72%)
Feb 21, 2025, 4:00 PM EST - Market closed
Acumen Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 84 | 222 | 221 | 274 | - | - |
| Market Cap Growth | -37.96% | 0.62% | -19.22% | - | - | - |
| Enterprise Value | -145 | -60 | 21 | 44 | - | - |
| Last Close Price | 1.39 | 3.84 | 5.40 | 6.76 | - | - |
| PB Ratio | 0.38 | 0.83 | 1.17 | 1.21 | - | - |
| P/TBV Ratio | 0.69 | 0.83 | 1.17 | 1.21 | - | - |
| Debt / Equity Ratio | 0.14 | 0.12 | 0.00 | - | - | - |
| Asset Turnover | - | - | - | - | 0.06 | - |
| Inventory Turnover | 414.90 | 284.97 | 229.51 | 141.44 | 114.24 | - |
| Quick Ratio | 10.08 | 18.81 | 22.75 | 37.76 | 6.89 | 4.90 |
| Current Ratio | 10.43 | 19.01 | 23.08 | 38.60 | 6.98 | 5.35 |
| Return on Equity (ROE) | -32.83% | -22.98% | -20.71% | -76.44% | -33.26% | - |
| Return on Assets (ROA) | -20.99% | -15.08% | -13.25% | -8.91% | -19.11% | - |
| Return on Capital (ROIC) | -22.02% | -15.70% | -13.66% | -9.30% | -22.46% | - |
| Earnings Yield | -97.80% | -23.55% | -19.39% | -36.77% | - | - |
| FCF Yield | -80.64% | -19.37% | -15.98% | -6.58% | - | - |
| Buyback Yield / Dilution | -34.18% | -19.72% | -102.43% | -4685.58% | 2.73% | - |
| Total Shareholder Return | -34.18% | -19.72% | -102.43% | -4685.58% | 2.73% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.